Should ESD be performed or referral considered for a rectal polyp with high malignancy risk based on JNET, KUDO, and CONNECT classifications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Rectal Polyp with High Malignancy Risk Based on JNET, KUDO, and CONNECT Classifications

For a rectal polyp showing high-risk features on JNET Type 3, KUDO Type V (VN or VI), or concerning CONNECT patterns, you should NOT attempt endoscopic resection if the lesion is non-pedunculated—instead, biopsy the area of surface disruption, tattoo the site (unless near the cecum), and refer directly to a colorectal surgeon. 1 However, if the lesion is pedunculated with these features, proceed with endoscopic polypectomy. 1

Understanding the Classification Systems and Risk Stratification

High-Risk Endoscopic Features Predicting Deep Submucosal Invasion

The following features indicate deep submucosal invasion with high specificity:

  • JNET Type 3: Characterized by loose vessel areas with interruption of thick vessels, and amorphous surface areas—this predicts deep submucosal invasive cancer 1
  • KUDO Type V: Specifically VN (loss or decrease of pits with amorphous structure) and VI (irregular arrangements and sizes of pits) patterns indicate deep invasion 1
  • NICE 3 features: Any one of three features (abnormal color, disrupted vessels, or amorphous surface pattern) has 94% accuracy and 96% negative predictive value for deep submucosal invasion 1

Additional concerning morphologic features include:

  • Paris 0-IIc morphology (depressed component) 1, 2
  • Dark brown coloration with areas of disrupted or missing vessels 1
  • Non-granular surface morphology, particularly in rectosigmoid location 2

Decision Algorithm Based on Polyp Morphology

For Non-Pedunculated (Sessile or Flat) Lesions

When you identify JNET Type 3, KUDO Type V, or NICE 3 features:

  1. Perform limited cold forceps biopsy only in the area of surface feature disruption to confirm histology 1
  2. Tattoo the lesion at 2-3 separate locations, 3-5 cm distal to the polyp (unless in cecum or near anal verge) 1
  3. Refer directly to colorectal surgery—do NOT attempt endoscopic resection 1

Critical pitfall to avoid: Excessive cold biopsy forceps tissue sampling or partial snare resection promotes scarring and fibrosis that makes subsequent curative resection more difficult 1

For Pedunculated Lesions

Even with high-risk features, pedunculated polyps should undergo endoscopic polypectomy because:

  • The stalk allows assessment of invasion depth using Haggitt classification 1
  • En-bloc resection provides intact specimen for accurate pathologic assessment 1
  • Hot snare polypectomy is recommended for pedunculated lesions >10 mm 3

After resection, histologic evaluation determines need for surgical resection based on:

  • Depth of submucosal invasion (>1000 μm requires surgery) 1
  • Presence of lymphovascular invasion 1
  • Poor differentiation 1
  • Positive margins 1

When ESD Might Be Considered (Requires Advanced Endoscopist)

ESD should only be performed by experienced endoscopists and is appropriate for:

  • T1 rectal cancers with superficial submucosal invasion (<1000 μm predicted) 1
  • Large complex polyps requiring en-bloc resection where EMR would result in piecemeal removal 1
  • Lesions without NICE 3 or KUDO V features but requiring complete resection 1

ESD advantages in the rectum specifically:

  • The rectum is below the peritoneal reflection, making ESD technically less challenging and safer than in other colon segments 1
  • En-bloc resection rates of 88.8% with R0 resection in 85.6% of cases 1
  • Curative resection achieved in 79.8% of rectal lesions 1
  • Low adverse event rate (5.9%) with no patients requiring surgery for complications 1

Risk Factors for Covert Malignancy

Even without obvious high-risk features, certain characteristics increase covert submucosal invasive cancer risk:

  • Rectosigmoid location (odds ratio 1.87) 2
  • Non-granular surface morphology (odds ratio 3.96-22.5) 2
  • Combined Paris classification (0-Is or 0-IIa+Is) 2
  • Increasing size (odds ratio 1.16 per 10 mm increase) 2

Rectosigmoid 0-Is and 0-IIa+Is non-granular lesions have particularly high malignancy risk and warrant referral to an advanced endoscopist or consideration for surgical evaluation. 2

Histologic Criteria for Curative Endoscopic Resection

If endoscopic resection is performed, curative resection requires ALL of the following:

  • En-bloc resection with negative horizontal and vertical margins 1
  • Submucosal invasion <1000 μm (SM1 level) 1
  • Well to moderately differentiated histology 1
  • No lymphovascular invasion 1
  • No tumor budding 1

If any criterion is not met, surgical resection with lymph node dissection is required because the risk of lymph node metastasis increases to 10-18% with deep submucosal invasion. 1

Summary of Action Steps

For your rectal polyp with high malignancy risk features:

  • Non-pedunculated: Biopsy, tattoo, refer to surgery—do not attempt resection 1
  • Pedunculated: Perform hot snare polypectomy, assess histology, then determine need for surgery based on pathologic risk factors 1, 3
  • If considering ESD: Refer to advanced endoscopist experienced in ESD technique, ensuring the lesion lacks overt deep invasion features 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Standard Procedure for Medical Polypectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.